KRYS 8-K 2026-01-08

Krystal Biotech, Inc. (KRYS) 8-K dated 2026-01-08 — accession 0001711279-26-000005. This URL is the filing, not the KRYS hub.

Krystal Biotech, Inc. (KRYS) is a biotechnology company listed on NASDAQ.

Krystal Biotech, Inc. filed a 8-K on 2026-01-08. Accession 0001711279-26-000005.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.

Not investment advice. The KRYS SEC hub lists recent forms. The stock page is the research view.